Zacks Investment Research
06 Jul 2026, 23:17 UTC · 2h ago
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: What You Should Know
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
06 Jul 2026, 23:17 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Oscar Health (OSCR) is expected to report quarterly EPS of $0.34, a 138.2% increase year-over-year. — Strong projected earnings growth typically drives positive investor sentiment and upward price pressure.
+0.60Oscar Health's projected quarterly revenue is $4.83 billion, representing a 68.58% increase from the prior-year quarter. — Significant revenue growth indicates strong business scaling and market share capture.
+0.50Oscar Health currently has a Forward P/E ratio of 68.47, significantly higher than its industry average of 9.94. — A high valuation premium relative to peers suggests the stock may be overvalued or priced for perfection, increasing downside risk.
-0.30Continue reading
6 related stories
Search tags
Oscar Health currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating suggests a neutral outlook with no immediate strong catalyst for a price swing.
Which stocks this story touches
The company shows strong growth projections with expected EPS and revenue increases, despite a short-term price dip.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
